Biomedical applications of mRNA nanomedicine
- PMID: 31007865
- PMCID: PMC6472920
- DOI: 10.1007/s12274-018-2146-1
Biomedical applications of mRNA nanomedicine
Abstract
As an attractive alternative to plasmid DNA, messenger RNA (mRNA) has recently emerged as a promising class of nucleic acid therapeutics for biomedical applications. Advances in addressing the inherent shortcomings of mRNA and in the development of nanoparticle-based delivery systems have prompted the development and clinical translation of mRNA-based medicines. In this review, we discuss the chemical modification strategies of mRNA to improve its stability, minimize immune responses, and enhance translational efficacy. We also highlight recent progress in nanoparticle-based mRNA delivery. Considerable attention is given to the increasingly widespread applications of mRNA nanomedicine in the biomedical fields of vaccination, protein-replacement therapy, gene editing, and cellular reprogramming and engineering.
Keywords: cellular reprogramming; chemical modification; engineering; gene editing; messenger RNA; nanoparticle; protein-replacement; vaccination.
References
-
- Brenner S., Jacob F., Meselson M. An unstable intermediate carrying information from genes to ribosomes for protein synthesis. Nature. 1961;190:576–581. - PubMed
-
- Gurdon J. B., Lane C. D., Woodland H. R., Marbaix G. Use of frog eggs and oocytes for the study of messenger RNA and its translation in living cells. Nature. 1971;233:177–182. - PubMed
-
- Wolff J. A., Malone R. W., Williams P., Chong W., Acsadi G., Jani A., Felgner P. L. Direct gene transfer into mouse muscle in vivo. Science. 1990;247:1465–1468. - PubMed
-
- Meng Z., O’Keeffe–Ahern J., Lyu J., Pierucci L., Zhou D. Z., Wang W. X. A new developing class of gene delivery: Messenger RNA–based therapeutics. Biomater. Sci. 2017;5:2381–2392. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials